Keyword Studios results not a hit with markets
Shares in AIM-listed Keyword Studio fell by 7.30% despite reporting that revenues for 2019 were around 30% higher than the…
6 years ago
Latest
Marlowe – continuing to make earnings enhancing acquisitions
Operating in an attractive sector and generating some impressive growth, Marlowe is one to watch, writes Mark Watson-Mitchell.
6 years ago
AstraZeneca: a stock for all seasons
Robert Stephens, CFA, discusses why pharmaceuticals giant AstraZeneca could produce capital growth in 2020 and beyond.
6 years ago
Evil Knievil: Lawyers go a-spoofing yet again
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
6 years ago
Energean Oil & Gas sinks after update
Shares in FTSE 250 oil & gas explorer Energean Oil & Gas fell by 2.92% to 799p as costs dwarfed…
6 years ago
Gattaca pulled down by weak fee income
Shares in Gattaca plunged by 13.80% after management said that underlying profits before tax for the year would be below…
6 years ago
Ergomed rises as it beats expectations
Pharmaceutical industry service provider Ergomed watched its share price climb by 6.98% as it said adjusted EBITDA for 2019 was…
6 years ago
Condor Gold: much closer to production
Stronger gold and a revised plan means this junior miner has cash flow in its sights much earlier than investors…
6 years ago
Why these 3 stocks could offer defensive appeal as the FTSE 100 falls
Robert Stephens, CFA, discusses the prospects for three stocks that could offer defensive characteristics in the wake of the coronavirus outbreak.
6 years ago
A.G. Barr shares sparkle on year-end news
Shares in FTSE 250 soft drinks producer A.G. Barr fizzed up by 13.97% after it published a trading update for…
6 years ago